Consultant-led education

Severe Late-onset VOD in Clinical Practice

Dr Varun Mehra presents the case of a 68-year-old male who developed late-onset VOD at day-56 post-HSCT.

Topics:

Case studies Diagnosis and severity grading Disease fundamentals Risk assessment and monitoring Treatment

ADVERSE EVENTS REPORTING

Adverse events should be reported. Reporting forms and information for the UK can be found at: https://yellowcard.mhra.gov.uk/

For Ireland, reporting forms and information can be found at: www.hpra.ie

Adverse events should also be reported to Jazz Pharmaceuticals at: AEreporting@jazzpharma.com

Defitelio® is indicated for the treatment of severe hepatic veno-occlusive disease (VOD) also known as sinusoidal obstruction syndrome (SOS) in haematopoietic stem-cell transplantation (HSCT) therapy. It is indicated in adults and in adolescents, children and infants over 1 month of age.